Sangamo Therapeutics
SGMO
#10618
Rank
HK$0.24 B
Marketcap
HK$0.58
Share price
0.00%
Change (1 day)
-88.86%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of March 2026 : -HK$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company has -HK$0.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-HK$0.12 Billion-162.8%
2024-12-31$HK$0.17 B-72.69%
2023-12-31$HK$0.64 B-71.91%
2022-12-31$HK$2.30 B-21.26%
2021-12-31$HK$2.92 B-24.09%
2020-12-31$HK$3.85 B14.4%
2019-12-31$HK$3.37 B17.19%
2018-12-31$HK$2.87 B95.9%
2017-12-31$HK$1.46 B39%
2016-12-31$HK$1.05 B-29.19%
2015-12-31$HK$1.49 B-6.94%
2014-12-31$HK$1.60 B69.82%
2013-12-31$HK$0.94 B87.62%
2012-12-31$HK$0.50 B-19.18%
2011-12-31$HK$0.62 B43.05%
2010-12-31$HK$0.43 B-21.83%
2009-12-31$HK$0.55 B30.02%
2008-12-31$HK$0.42 B-23.88%
2007-12-31$HK$0.56 B48.45%
2006-12-31$HK$0.37 B29.2%
2005-12-31$HK$0.29 B16.52%
2004-12-31$HK$0.25 B-27.32%
2003-12-31$HK$0.34 B-18.17%
2002-12-31$HK$0.42 B-34.12%
2001-12-31$HK$0.64 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
HK$666.78 B-448,377.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$91.71 B-61,761.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$147.90 B-99,535.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
HK$136.28 B-91,722.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$92.15 B-62,057.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$329.45 B-221,593.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$10.62 B-7,243.87%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$49.60 B-33,451.04%๐Ÿ‡บ๐Ÿ‡ธ USA